Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant added to metformin in type 2 diabetes insufficiently controlled with metformin
2007-004833-40Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Rimonabant + metformin with Placebo + metformin (2 arms). Primary endpoint: Change in HbA1c at Week 36 from baseline. Started Mar 2008; status: terminated.
02
Drugs
rimonabant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-004833-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004833-40.